News

Required Reporting of Modifier JW Postponed Until January 2017

June 10, 2016

The Centers for Medicare & Medicaid Services (CMS) released a Change Request (CR) 9603 for a change in policy regarding the use of the JW modifier for discarded Part B drugs and biologicals.

Effective January 1, 2017, providers are required to:

  • Use the JW modifier for claims with unused drugs or biologicals from single use vials or single use packages that are appropriately discarded (except those provided under the Competitive Acquisition Program (CAP) for Part B drugs and biologicals) and
  • Document the discarded drug or biological in the patient's medical record when submitting claims with unused Part B drugs or biologicals from single use vials or single use packages that are appropriately discarded

Read the complete CMS bulletin